Man Group PLC Prothena Corp Public LTD CO Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Man Group PLC holds 40,529 shares of PRTA stock, worth $698,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,529

Previous 29,679 36.56%

Holding current value

$698,314

Previous $735,000 13.74%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$19.54 - $26.15 $212,009 - $283,727	10,850 Added 36.56%	40,529 $836,000
Q1 2024 May 15, 2024	SELL	$24.75 - $40.66 $67,443 - $110,798	-2,725 Reduced 8.41%	29,679 $735,000
Q4 2023 Feb 14, 2024	BUY	$32.31 - $52.32 $893,274 - $1.45 Million	27,647 Added 581.19%	32,404 $1.18 Million
Q3 2023 Nov 14, 2023	SELL	$47.3 - $70.6 $7.84 Million - $11.7 Million	-165,805 Reduced 97.21%	4,757 $229,000
Q2 2023 Aug 14, 2023	BUY	$48.26 - $78.59 $2.54 Million - $4.14 Million	52,685 Added 44.69%	170,562 $11.6 Million
Q1 2023 May 15, 2023	BUY	$46.97 - $58.27 $4.42 Million - $5.49 Million	94,180 Added 397.43%	117,877 $5.71 Million
Q4 2022 Feb 14, 2023	SELL	$52.05 - $65.0 $1.41 Million - $1.76 Million	-27,019 Reduced 53.28%	23,697 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$25.16 - $60.63 $158,004 - $380,756	6,280 Added 14.13%	50,716 $3.08 Million
Q2 2022 Aug 15, 2022	BUY	$22.73 - $39.98 $1.01 Million - $1.78 Million	44,436 New	44,436 $1.21 Million
Q1 2021 May 17, 2021	SELL	$11.0 - $28.24 $759,253 - $1.95 Million	-69,023 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$10.12 - $13.94 $7,083 - $9,758	-700 Reduced 1.0%	69,023 $829,000
Q3 2020 Nov 16, 2020	BUY	$9.93 - $13.47 $23,832 - $32,328	2,400 Added 3.56%	69,723 $697,000
Q2 2020 Aug 14, 2020	SELL	$9.56 - $12.51 $26,768 - $35,028	-2,800 Reduced 3.99%	67,323 $704,000
Q1 2020 May 15, 2020	SELL	$7.54 - $15.77 $48,587 - $101,621	-6,444 Reduced 8.42%	70,123 $750,000
Q4 2019 Feb 18, 2020	SELL	$7.48 - $17.01 $145,530 - $330,946	-19,456 Reduced 20.26%	76,567 $1.21 Million
Q3 2019 Nov 14, 2019	SELL	$6.89 - $10.45 $441,256 - $669,249	-64,043 Reduced 40.01%	96,023 $753,000
Q2 2019 Aug 14, 2019	BUY	$8.85 - $12.49 $284,899 - $402,078	32,192 Added 25.17%	160,066 $1.69 Million
Q1 2019 May 15, 2019	BUY	$10.32 - $14.49 $18,576 - $26,082	1,800 Added 1.43%	127,874 $1.55 Million
Q4 2018 Feb 14, 2019	SELL	$8.73 - $13.74 $267,417 - $420,883	-30,632 Reduced 19.55%	126,074 $1.3 Million
Q3 2018 Nov 14, 2018	SELL	$12.7 - $15.79 $783,590 - $974,243	-61,700 Reduced 28.25%	156,706 $2.05 Million
Q2 2018 Aug 14, 2018	BUY	$10.99 - $44.21 $2.4 Million - $9.66 Million	218,406 New	218,406 $3.18 Million

Others Institutions Holding PRTA

# of Institutions

180

Shares Held

43.1M

Call Options Held

77.7K

Put Options Held

81K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $808M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account